Redmile Group, LLC
- SEC CIK
- 0001425738
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 86
- 0 vs. Q1 2021
- Portfolio value
- $6.76B
- −$341.9M (−4.8%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| FATEFate Therapeutics Inc | COM | 12,957,222 | $1.12B | 16.6% | 00.0% | Unchanged | History |
| IGMSIGM Biosciences, Inc. | COM | 3,425,455 | $285.0M | 4.2% | 00.0% | Unchanged | History |
| BEAMBeam Therapeutics Inc. | COM | 2,052,506 | $264.2M | 3.9% | −480,017−19.0% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 790,282 | $237.9M | 3.5% | −59,563−7.0% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 20,799,303 | $200.5M | 3.0% | −314,811−1.5% | Reduced | History |
| ALLKAllakos Inc. | COM | 2,216,996 | $189.3M | 2.8% | −202,422−8.4% | Reduced | History |
| ADCTADC Therapeutics SA | SHS | 7,522,029 | $183.2M | 2.7% | +213,611+2.9% | Added | History |
| STTKShattuck Labs, Inc. | COM | 5,619,914 | $162.9M | 2.4% | 00.0% | Unchanged | History |
| REPLReplimune Group, Inc. | COM | 4,191,512 | $161.0M | 2.4% | +73,300+1.8% | Added | History |
| NVTAInvitae Corp | COM | 4,647,393 | $156.8M | 2.3% | −204,770−4.2% | Reduced | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 4,244,721 | $155.4M | 2.3% | −106,923−2.5% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 860,101 | $152.8M | 2.3% | +30,942+3.7% | Added | History |
| MDVLMedAvail Holdings, Inc. | COM | 11,724,726 | $143.6M | 2.1% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 2,072,132 | $140.9M | 2.1% | +12,000+0.6% | Added | History |
| OSHOak Street Health, Inc. | COM | 2,302,653 | $134.9M | 2.0% | −627,758−21.4% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 2,531,508 | $122.8M | 1.8% | −71,631−2.8% | Reduced | History |
| SGENSeagen Inc. | COM | 771,385 | $121.8M | 1.8% | −165,660−17.7% | Reduced | History |
| VERVVerve Therapeutics, Inc. | COM | 1,936,530 | $116.7M | 1.7% | +1,936,530 | New | History |
| SKINSkinHealth Systems Inc. | COM CL A | 6,353,246 | $106.7M | 1.6% | +6,353,246 | New | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 3,012,081 | $100.7M | 1.5% | −375,707−11.1% | Reduced | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 6,449,577 | $100.3M | 1.5% | −435,656−6.3% | Reduced | History |
| NVRONevro Corp | COM | 594,732 | $98.6M | 1.5% | +77,937+15.1% | Added | History |
| DXCMDexcom Inc | COM | 230,558 | $98.4M | 1.5% | +8,100+3.6% | Added | History |
| LIVNLivaNova PLC | SHS | 1,111,684 | $93.5M | 1.4% | −8,146−0.7% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 3,156,401 | $91.9M | 1.4% | −50,792−1.6% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 3,190,077 | $84.6M | 1.3% | −124,040−3.7% | Reduced | History |
| RGNXREGENXBIO Inc. | COM | 2,138,201 | $83.1M | 1.2% | −202,112−8.6% | Reduced | History |
| STOKStoke Therapeutics, Inc. | COM | 2,458,558 | $82.8M | 1.2% | −85,504−3.4% | Reduced | History |
| RPTXRepare Therapeutics Inc. | COM | 2,624,396 | $81.8M | 1.2% | −41,100−1.5% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 3,425,038 | $77.1M | 1.1% | −33,792−1.0% | Reduced | History |
| EPZMEpizyme, Inc. | COM | 8,515,060 | $70.8M | 1.0% | −309,306−3.5% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 2,804,944 | $69.6M | 1.0% | +291,198+11.6% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 2,307,028 | $66.7M | 1.0% | +130,400+6.0% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 1,215,657 | $62.5M | 0.9% | −641,415−34.5% | Reduced | History |
| ZYZymergen Inc. | COM | 1,522,900 | $60.9M | 0.9% | +1,522,900 | New | History |
| IMGNImmunoGen, Inc. | COM | 8,880,945 | $58.5M | 0.9% | −807,121−8.3% | Reduced | History |
| ONEM1Life Healthcare Inc | COM | 1,666,963 | $55.1M | 0.8% | +1,104,649+196.4% | Added | History |
| NGMNGM Biopharmaceuticals Inc | COM | 2,792,448 | $55.1M | 0.8% | +40,633+1.5% | Added | History |
| TCRRTCR2 Therapeutics Inc. | COM | 3,235,809 | $53.1M | 0.8% | −374,979−10.4% | Reduced | History |
| GMABGenmab A/S | SPONSORED ADS | 1,227,588 | $50.1M | 0.7% | −104,624−7.9% | Reduced | History |
| ALXOAlx Oncology Holdings Inc | COM | 914,035 | $50.0M | 0.7% | −64,565−6.6% | Reduced | History |
| SLQTSelectQuote, Inc. | COM | 2,411,957 | $46.5M | 0.7% | +406,903+20.3% | Added | History |
| ICUIIcu Medical Inc | COM | 222,929 | $45.9M | 0.7% | −1,225−0.5% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 4,541,009 | $42.3M | 0.6% | 00.0% | Unchanged | History |
| ELVElevance Health, Inc. | Stock | 108,801 | $41.5M | 0.6% | −21,604−16.6% | Reduced | History |
| CRLCharles River Laboratories International, Inc. | COM | 108,374 | $40.1M | 0.6% | −58,305−35.0% | Reduced | History |
| CICigna Group | Stock | 159,727 | $37.9M | 0.6% | −120,330−43.0% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 94,465 | $37.8M | 0.6% | −19,911−17.4% | Reduced | History |
| NGNENeurogene Inc. | COM | 3,919,235 | $36.2M | 0.5% | −198,334−4.8% | Reduced | History |
| LFSTLifeStance Health Group, Inc. | COM | 1,257,067 | $35.0M | 0.5% | +1,257,067 | New | History |
| CTLTCatalent, Inc. | COM | 310,111 | $33.5M | 0.5% | −1,508−0.5% | Reduced | History |
| ZYMEZymeworks Inc. | COM | 939,697 | $32.6M | 0.5% | −46,003−4.7% | Reduced | History |
| AMEDAmedisys Inc | COM | 132,458 | $32.4M | 0.5% | −522−0.4% | Reduced | History |
| KLRSKalaris Therapeutics, Inc. | COM | 1,584,093 | $31.3M | 0.5% | −359,494−18.5% | Reduced | History |
| LVTXLAVA Therapeutics NV | SHS | 2,816,196 | $30.6M | 0.5% | −8,213−0.3% | Reduced | History |
| RCELAVITA Medical, Inc. | COM | 1,411,117 | $29.0M | 0.4% | −257,210−15.4% | Reduced | History |
| ARDXArdelyx, Inc. | COM | 3,714,100 | $28.2M | 0.4% | +200,000+5.7% | Added | History |
| BVSBioventus Inc. | COM CL A | 1,486,956 | $26.2M | 0.4% | −13,044−0.9% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 425,480 | $22.6M | 0.3% | −1,795,564−80.8% | Reduced | History |
| IMTXImmatics N.V. | SHS | 1,941,892 | $22.5M | 0.3% | −140,922−6.8% | Reduced | History |
| PPDPPD, Inc. | COM | 466,471 | $21.5M | 0.3% | −354,621−43.2% | Reduced | History |
| BCELAtreca, Inc. | CL A COM | 2,460,268 | $21.0M | 0.3% | −30,300−1.2% | Reduced | History |
| QSIQuantum-Si Inc | COM CL A | 1,700,000 | $20.8M | 0.3% | +1,700,000 | New | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,088,089 | $20.4M | 0.3% | 00.0% | Unchanged | – |
| GRTSGritstone bio, Inc. | COM | 2,226,206 | $20.3M | 0.3% | −221,952−9.1% | Reduced | History |
| Itamar Med Ltd465437101 | SPONSORED ADS | 854,900 | $20.1M | 0.3% | −64,000−7.0% | Reduced | – |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 2,012,900 | $20.0M | 0.3% | +2,012,900 | New | – |
| INNVInnovAge Holding Corp. | COM | 843,578 | $18.0M | 0.3% | −6,422−0.8% | Reduced | History |
| STXSStereotaxis, Inc. | COM NEW | 1,855,504 | $17.9M | 0.3% | −1,386,099−42.8% | Reduced | History |
| TKNOAlpha Teknova, Inc. | COM | 725,000 | $17.2M | 0.3% | +725,000 | New | History |
| HOOKHOOKIPA Pharma Inc. | COM | 1,856,205 | $17.0M | 0.3% | +13,303+0.7% | Added | History |
| QTRXQuanterix Corp | COM | 240,933 | $14.1M | 0.2% | −59,067−19.7% | Reduced | History |
| PROFProfound Medical Corp. | COM NEW | 787,346 | $12.9M | 0.2% | −58,328−6.9% | Reduced | History |
| TMCITreace Medical Concepts, Inc. | COM | 323,765 | $10.1M | 0.1% | +323,765 | New | History |
| CTSOCytosorbents Corp | COM NEW | 1,304,369 | $9.85M | 0.1% | −823,262−38.7% | Reduced | History |
| AYLAOld Ayala, Inc | COM | 667,816 | $6.80M | 0.1% | 00.0% | Unchanged | History |
| STIMNeuronetics, Inc. | COM | 394,355 | $6.32M | 0.1% | −105,645−21.1% | Reduced | History |
| CABACabaletta Bio, Inc. | COM | 696,378 | $5.99M | 0.1% | 00.0% | Unchanged | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 1,358,825 | $5.53M | 0.1% | −353,479−20.6% | Reduced | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 237,360 | $5.10M | 0.1% | −920,722−79.5% | Reduced | History |
| TLISTalis Biomedical Corp | COM | 363,849 | $4.01M | 0.1% | −36,151−9.0% | Reduced | History |
| APREAprea Therapeutics, Inc. | COM | 694,918 | $3.39M | 0.1% | 00.0% | Unchanged | History |
| KAKineta, Inc. | COM | 59,487 | $693.0K | <0.1% | −551,516−90.3% | Reduced | History |
| TCDATricida, Inc. | COM | 54,758 | $237.0K | <0.1% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 38,912 | $212.0K | <0.1% | −173,379−81.7% | Reduced | History |
| OVIDOvid Therapeutics Inc. | COM | 40,674 | $159.0K | <0.1% | −81,276−66.6% | Reduced | History |
Sold out since Q1 2021 (8)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| MDTMedtronic plc | Stock | 979,108 | $115.7M | 1.6% | History |
| Genmark Diagnostics Inc372309104 | COM | 3,589,342 | $85.8M | 1.2% | – |
| BIIBBiogen Inc. | COM | 162,847 | $45.6M | 0.6% | History |
| Vesper Healthcare Acqstn Cor92538T104 | COM CL A | 1,982,749 | $21.4M | 0.3% | – |
| QUREuniQure N.V. | SHS | 284,160 | $9.57M | 0.1% | History |
| DVAXDynavax Technologies Corp | COM NEW | 882,814 | $8.68M | 0.1% | History |
| WVEWave Life Sciences, Inc. | SHS | 79,018 | $443.0K | <0.1% | History |
| CSLTCastlight Health, Inc. | CL B | 10,229 | $15.0K | <0.1% | History |